Clarivate (CLVT) Stock Forecast, Price & News

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Clarivate in the last year. There are currently 2 sell ratings, 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CLVT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLVT, but not buy additional shares or sell existing shares.
View CLVT analyst ratings or view top-rated stocks.

8 analysts have issued 12-month price objectives for Clarivate's shares. Their CLVT share price forecasts range from $6.00 to $11.00. On average, they anticipate the company's share price to reach $8.31 in the next year. This suggests a possible upside of 15.3% from the stock's current price.
View analysts price targets for CLVT or view top-rated stocks among Wall Street analysts.

Clarivate's stock was trading at $8.34 at the start of the year. Since then, CLVT stock has decreased by 13.5% and is now trading at $7.21.
View the best growth stocks for 2023 here.

Clarivate saw a increase in short interest in September. As of September 15th, there was short interest totaling 53,720,000 shares, an increase of 6.4% from the August 31st total of 50,490,000 shares. Based on an average daily volume of 6,260,000 shares, the short-interest ratio is currently 8.6 days. Approximately 12.9% of the company's shares are short sold.
View Clarivate's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our CLVT earnings forecast.

Clarivate Plc (NYSE:CLVT) released its quarterly earnings data on Thursday, August, 3rd. The company reported $0.21 EPS for the quarter, topping the consensus estimate of $0.19 by $0.02. The company had revenue of $668.80 million for the quarter, compared to analyst estimates of $673.97 million. Clarivate had a negative net margin of 159.90% and a positive trailing twelve-month return on equity of 9.65%. The company's revenue for the quarter was down 2.6% on a year-over-year basis. During the same period in the prior year, the company earned $0.19 EPS.

iShares MSCI USA Size Factor ETF holds 68,505 shares of CLVT stock, representing 0.20% of its portfolio.

Clarivate issued an update on its FY 2023 earnings guidance on Thursday, August, 3rd. The company provided EPS guidance of $0.77-$0.83 for the period, compared to the consensus EPS estimate of $0.83. The company issued revenue guidance of $2.60 billion-$2.67 billion, compared to the consensus revenue estimate of $2.68 billion.

Clarivate trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLVT."

Clarivate's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Impactive Capital LP (4.23%), BlackRock Inc. (3.73%), Brahman Capital Corp. (1.65%), State Street Corp (1.39%), Invenomic Capital Management LP (0.99%) and Geode Capital Management LLC (0.95%). Insiders that own company stock include Andrew Miles Snyder, Blucher Sheryl G Von, Corp Onex, James Gordon Samson, Jeff Roy, Mukhtar Ahmed, Richard Hanks and Richard Roedel.
View institutional ownership trends.

Shares of CLVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CLVT stock can currently be purchased for approximately $7.21.

Clarivate (NYSE:CLVT) has a market capitalization of $4.88 billion and generates $2.66 billion in revenue each year. The company earns $-3,960,200,000.00 in net income (profit) each year or ($6.37) on an earnings per share basis.

The company employs 11,800 workers across the globe.

Clarivate's mailing address is 160 Blackfriars Road, London X0, SE1 8EZ. The official website for the company is www.clarivate.com. The company can be reached via phone at 442074334000 or via email at investor.relations@clarivate.com.